These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19033715)

  • 61. Epidermal growth factor receptor in colorectal carcinoma: correlation with clinico-pathological prognostic factors.
    Abd El All HS; Mishriky AM; Mohamed FA
    Colorectal Dis; 2008 Feb; 10(2):170-8. PubMed ID: 17711501
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinoma.
    Sirak I; Petera J; Hatlova J; Vosmik M; Melichar B; Dvorak J; Zoul Z; Tycova V; Lesko M; Hajduch M
    Strahlenther Onkol; 2008 Nov; 184(11):592-7. PubMed ID: 19016018
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
    Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
    World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of epidermal growth factor receptor in primary colorectal adenocarcinoma predicts expression in recurrent disease.
    Khalifa MA; Rowsell CH; Gladdy RA; Ko YJ; Hanna S; Smith A; Law C
    Am J Clin Pathol; 2006 Feb; 125(2):229-33. PubMed ID: 16393679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
    Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
    Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A role for IGF-1R-targeted therapies in small-cell lung cancer?
    Gately K; Collins I; Forde L; Al-Alao B; Young V; Gerg M; Feuerhake F; O'Byrne K
    Clin Lung Cancer; 2011 Jan; 12(1):38-42. PubMed ID: 21273178
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.
    Chakravarty G; Santillan AA; Galer C; Adams HP; El-Naggar AK; Jasser SA; Mohsin S; Mondal D; Clayman GL; Myers JN
    Exp Biol Med (Maywood); 2009 Apr; 234(4):372-86. PubMed ID: 19176870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical significance of basal-like subtype in triple-negative breast cancer.
    Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
    Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
    Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
    Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 71. EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer.
    Nogi H; Kobayashi T; Suzuki M; Tabei I; Kawase K; Toriumi Y; Fukushima H; Uchida K
    Oncol Rep; 2009 Feb; 21(2):413-7. PubMed ID: 19148516
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.
    Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP
    Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High expression of HER3 is associated with a decreased survival in gastric cancer.
    Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
    Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies.
    Hayati AR; Cheah FC; Tan AE; Tan GC
    Early Hum Dev; 2007 Jan; 83(1):41-6. PubMed ID: 16750336
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of colorectal cancer.
    Cohen AM
    Compr Ther; 1990 Nov; 16(11):43-50. PubMed ID: 2269015
    [No Abstract]   [Full Text] [Related]  

  • 78. Epidermal growth factor receptors in colorectal carcinoma.
    Moorghen M; Ince P; Finney KJ; Watson AJ; Harris AL
    Anticancer Res; 1990; 10(3):605-11. PubMed ID: 2195985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.
    Shan HB; Zhang R; Li Y; Xu GL; Luo GY; Gao XY; Yang HL
    Technol Cancer Res Treat; 2011 Aug; 10(4):381-9. PubMed ID: 21728395
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
    Hartog H; Wesseling J; Boezen HM; van der Graaf WT
    Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.